GCG and pancreatitis: These miRNAs may be able to detect the degree of injury more sensitively than traditional biomarkers, and may be useful for monitoring idiosyncratic pancreatitis or the effects of compounds known to target the pancreas, such as incretin-based compounds, during the drug development process.